Track topics on Twitter Track topics that are important to you
Many unanswered questions surrounding the nascent biosimilar market are creating challenges â though less regulated markets may benefit from 'less well defined' definitions, says analyst.
Original Article: Biosimilar sales remain small in 'largely untapped' marketNEXT ARTICLE
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...